Radcliffe Capital Management’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Radcliffe Capital Management’s Portfolio HCAR Stock Details HCAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-810,178	Closed	-$8.04M	–	1006
2022 Q3	$8.04M	Buy	810,178 +53,720	+7%	+$531K	0.19%	98
2022 Q2	$7.44M	Hold	756,458	–	–	0.17%	116
2022 Q1	$7.41M	Hold	756,458	–	–	0.17%	100
2021 Q4	$7.38M	Hold	756,458	–	–	0.19%	68
2021 Q3	$7.38M	Hold	756,458	–	–	0.21%	48
2021 Q2	$7.32M	Hold	756,458	–	–	0.23%	36
2021 Q1	$7.32M	Buy	+756,458	New	+$7.58M	0.29%	35

Radcliffe Capital Management's HCAR Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 810,178 shares — an estimated $8.04M sold.

Radcliffe Capital Management first reported a position in HCAR in Q1 2021 and held it in 7 quarters. The position peaked at $8.04M in Q3 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

Radcliffe Capital Management reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 810,178 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $8.04M.
Radcliffe Capital Management first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2021 and held it in 7 quarters.
Radcliffe Capital Management's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $8.04M in Q3 2022.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.